Synergy Pharma Consulting Limited members' voluntary liquidation
Active Company no. 08810551 Incorporated Dec 2013 Professional Services HA postcode area
C/O Neum Insolvency, Suite 9, Amba House, 15 College Road, Harrow, HA1 1BA
The most recent insolvency notice for Synergy Pharma Consulting Limited is a Notices to creditors (MVL), published 20 October 2026 in The London Gazette. The office holder is Umang Patel, appointed 15 October 2026. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Last filed balance sheet
Not yet retrieved.
Insolvency notices (3)
-
Notices to creditors (MVL) 20 Oct 2026
Creditors of Synergy Pharma Consulting Limited must submit their claims by 30 November 2026 as part of the company's voluntary liquidation.
-
Appointment of liquidators (MVL) 20 Oct 2026
Members have appointed Umang Patel of Neum Insolvency as liquidator of Synergy Pharma Consulting Limited effective 15 October 2026.
-
Resolution for winding up (MVL) 20 Oct 2026
Synergy Pharma Consulting Limited has resolved to voluntarily wind up and appointed Umang Patel as liquidator.
What happens next
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Owed money by Synergy Pharma Consulting Limited?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
Frequently asked questions
Is Synergy Pharma Consulting Limited in financial difficulty?
No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Synergy Pharma Consulting Limited (company no. 08810551) is a Notices to creditors (MVL), published 20 October 2026 in The London Gazette.
What were Synergy Pharma Consulting Limited's last filed accounts?
Not yet retrieved for Synergy Pharma Consulting Limited at Companies House.
How many insolvency notices does Synergy Pharma Consulting Limited have?
Synergy Pharma Consulting Limited has 3 insolvency notices recorded in The London Gazette, the most recent being a Notices to creditors (MVL) on 20 October 2026.
What happens next?
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.